Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

Wyeth

Status and phase: Completed; Phase 1

Conditions: Vasomotor Symptoms

Treatments: Drug: desvenlafaxine succinate sustained release (DVS SR)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00397176

3151A2-1200

Details and patient eligibility

About

Safety, tolerability, and pharmacokinetics (PK) of desvenlafaxine succinate sustained release (DVS SR) in healthy Japanese female subjects.

Sex: Female

Ages: 20 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy, first-generation (born in Japan, living in the US for less than 5 years)
• Japanese female subjects

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind